Cancer, in any form has no cure as of now. The last few decades have seen varied forms of cancer, predominantly breast cancer, liver cancer, pancreatic cancer and more. As people all over the world are aware of cancer being associated with numerous other diseases that involve unregulated cell growth, it had been understood that people with Hepatitis B are more likely to develop liver cancer than those people who are not affected by the Hepatitis B virus leading to inflammation of the liver causing fatty livers and more. In this Health Blog, we would bring to you a latest development that takes another step towards prevention of liver cancer.
A published research analysis in the Journal of Clinical Oncology clearly states that people who have high levels of cholesterol are infected by Hepatitis B are more likely to develop liver cancer and such risks can be substantially reduced if the patients are prescribed Statins. Now, Statins are also known for its prevention properties of breast cancer and the latest findings that they can also play a major prevention role in liver cancer especially among those who have Hepatitis B. This Latest Health News comes as a pleasant surprise and numerous doctors are claiming this to be an exciting development and solid research.
The study was conducted on more than thirty thousand individuals over a decade to follow them through their journey with Hepatitis B and their prescribed dosage of Statins. The result showed that they have the least possibility of developing liver cancer compared to those who were not on prescribed Statin. While the news is great for people having high cholesterols since Statins work wonders in those cases, people with Hepatitis B cannot be completely certain of not developing Liver Cancer after being prescribed the drug. It albeit reduces the risk but the study did turn up more than thousand patients who developed liver cancer while the study was being conducted through a period of ten years.
It is understood that more research would have to be conducted to see how further the liver cancer risk potential can be reduced in case of people with Hepatitis B.
Some experts are also cautious to jump to conclusions since there are opinions that people with cirrhosis in their livers should not be out rightly suggested Statins. The primary reason is that cirrhosis, a process where healthy tissues in the liver are replaced by scar tissues, is almost on every occasion among the first stages of developing liver cancer and thus, more research needs to be carried out to validate the findings among different people. A certain breakthrough in a specific category may have adverse implications in patients who also have other problems.
Keep a watch on our Health Blogs for more updates on the same!